d dosage production industry. (MCC) Metropolitan Computing Corporation will be installing its latest Instrumentation, data acquisition, and calibration equipment on some of the large commercial tablets presses in production for Tecnoquimicas, which manufactures products for McKesson and many other brands in Colombia, South America. Unity Management Group, Inc.
About Tecnoquimicas
Tecnoquimicas has been in production more than 75 years. Throughout its history, prestigious multinational companies have found Tecnoquimicas to be their best strategic partner in Colombia and have trusted us to manufacture and market their products.
About Unity Management Group, Inc.: Unity Management Group, a health resource company, will continue to provide innovative physician practice management services that offer high value and significant return on investment for physicians practices and hospitals through its three subsidiary companies: United Healthcare Solutions Inc., Unity Technologies Inc., and United Business Services Inc.
The first subsidiary, Unity Business Services, is a full service management company offering solutions in practice management, billing, staffing, contracting, licensing, credentialing, and accounting. Unity Business Services also offers assistance in HIPAA compliance, marketing, and unique solutions for practice start-ups and new practices.
Unity Technologies Inc. is a complete software solutions company offering billing, electronic medical records, and electronic health records for physicians' offices and hospitals.
United Healthcare Solutions, a national company based in Nevada, is a healthcare company will be providing medical, vision and dental plans, as well as PPO and HMO networks.
For more information please go to our website, which can be found at www.unitymanagementgroup.com w
'/>"/>
SOURCE Unity Management Group, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine technology :1.
TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)2.
WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO3.
Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research4.
FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia5.
Hospital to Hold MRSA Briefing for Media and Community Leaders6.
On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS7.
New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity8.
Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections9.
Access Pharmaceuticals to Conduct Conference Call to Update Financial Community10.
Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 200811.
Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA